Financial Enhancement Group LLC Eli Lilly & CO Transaction History

Financial Enhancement Group LLC

$569 Million
Q3 2024

A detailed history of Financial Enhancement Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Enhancement Group LLC holds 1,862 shares of LLY stock, worth $1.4 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,862

Previous 2,309 19.36%

Holding current value

$1.4 Million

Previous $2.09 Million 21.1%

% of portfolio

0.29%

Previous 0.34%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $345,146 - $429,128	-447 Reduced 19.36%	1,862 $1.65 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $317,493 - $398,159	438 Added 23.41%	2,309 $2.09 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $5,329 - $7,130	9 Added 0.48%	1,871 $1.46 Million
Q1 2023 May 17, 2023	BUY	$310.63 - $364.82 $11,182 - $13,133	36 Added 1.97%	1,862 $639,000
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $40,193 - $46,833	-125 Reduced 6.41%	1,826 $668,000
Q1 2022 May 18, 2022	SELL	$234.69 - $291.66 $98,569 - $122,497	-420 Reduced 17.71%	1,951 $559,000
Q4 2021 Jan 28, 2022	BUY	$224.85 - $279.04 $12,141 - $15,068	54 Added 2.33%	2,371 $655,000
Q3 2021 Oct 14, 2021	SELL	$221.6 - $272.71 $21,495 - $26,452	-97 Reduced 4.02%	2,317 $535,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $29,413 - $38,076	179 Added 8.01%	2,414 $451,000
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $47,617 - $63,009	365 Added 19.52%	2,235 $377,000
Q3 2020 Nov 18, 2020	BUY	$146.22 - $169.13 $5,117 - $5,919	35 Added 1.91%	1,870 $277,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $50,475 - $60,746	370 Added 25.26%	1,835 $301,000
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $13,348 - $14,520	125 Added 9.33%	1,465 $164,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $16,124 - $18,505	-213 Reduced 13.72%	1,340 $114,000
Q1 2018 Apr 30, 2018	BUY	$74.21 - $87.6 $115,248 - $136,042	1,553 New	1,553 $120,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.

Account

Financial Enhancement Group LLC Eli Lilly & CO Transaction History